Evidence map›Paper›PMID 39087344›Full record

ArticleCirculation2024

Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).

Irene Martinez-Morata, Kathrin Schilling, Ronald A Glabonjat, Arce Domingo-Relloso, Melanie Mayer, Katlyn E McGraw, Marta Galvez Fernandez, Tiffany R Sanchez, Anne E Nigra, Joel D Kaufman and 9 more

Abstract read
In one paragraph

Article in Circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The predictive value of multiple urinary metals in evaluating death risk in asthmatic individuals: a prospective cohort study.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Irene Martinez-MorataDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0003-3165-4931
Kathrin SchillingDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0003-4147-0298
Ronald A GlabonjatDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.
Arce Domingo-RellosoDepartment of Biostatistics (A.D.-R., M.M., L.V.), Columbia University, New York, NY.ORCID 0000-0001-6928-8290
Melanie MayerDepartment of Biostatistics (A.D.-R., M.M., L.V.), Columbia University, New York, NY.ORCID 0000-0002-0556-5313
Katlyn E McGrawDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0003-1143-3920
Marta Galvez FernandezDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0003-1996-7425
Tiffany R SanchezDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0001-8601-307X
Anne E NigraDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0002-5033-0345
Joel D KaufmanDepartment of Epidemiology, University of Washington, Seattle (J.D.K.).ORCID 0000-0003-4174-9037
Dhananjay VaidyaJohns Hopkins University, Baltimore, MD (D.V., W.S.P.).ORCID 0000-0002-7164-1601
Miranda R JonesDepartment of Medicine, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (M.R.J., W.S.P.).ORCID 0000-0003-4863-104X
Michael P BancksDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC (M.P.B.).ORCID 0000-0003-3694-6060
R Graham BarrMailman School of Public Health, Department of Medicine, Irving Medical Center (R.G.B., D.S., S.S.), Columbia University, New York, NY.
Daichi ShimboMailman School of Public Health, Department of Medicine, Irving Medical Center (R.G.B., D.S., S.S.), Columbia University, New York, NY.ORCID 0000-0001-6302-8834
Wendy S PostDepartment of Medicine, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (M.R.J., W.S.P.).ORCID 0000-0002-8655-5204
Linda ValeriDepartment of Biostatistics (A.D.-R., M.M., L.V.), Columbia University, New York, NY.
Steven SheaMailman School of Public Health, Department of Medicine, Irving Medical Center (R.G.B., D.S., S.S.), Columbia University, New York, NY.ORCID 0000-0002-7382-0603
Ana Navas-AcienDepartment of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.ORCID 0000-0001-9824-7797

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Steven N. Chillrud · 1998 to 2026
$44.7M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
Task Area A Core Study Operations.Task Area A shall encompass annual follow-up of cohort members, clinical endpoints ascertainment, study coordination activities, maintenance of the database and biosp75N92020D00001 · NHLBI · UNIVERSITY OF WASHINGTON · PI MCCLELLAND, ROBYN LEAGH · 2020 to 2025
$17.2M
Supplemental Training in Making Data FAIR and AI/ML ReadyT32ES007322 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Pam R Factor-Litvak, Allison Kupsco · 2000 to 2026
$12.1M
Research Experience and Training Coordination CoreP42ES033719 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ana Navas-Acien · 2022 to 2026
$11.9M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
TO EXERCISE OPTION PERIOD ONE (1) FOR TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.75N92020D00004 · NHLBI · NORTHWESTERN UNIVERSITY · PI SIEGEL, JONATHAN H · 2020 to 2025
$4.5M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00006 · NHLBI · UNIVERSITY OF MINNESOTA · PI PANKOW, JAMES S · 2020 to 2025
$4.4M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00003 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POST, WENDY S · 2020 to 2025
$3.8M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001420NHLBI NIH HHS 75N92020D00001NHLBI NIH HHS 75N92020D00002NHLBI NIH HHS 75N92020D00003NHLBI NIH HHS 75N92020D00004NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS 75N92020D00006NHLBI NIH HHS 75N92020D00007NHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01 HC095160NHLBI NIH HHS N01 HC095161NHLBI NIH HHS N01 HC095162NHLBI NIH HHS N01 HC095163NHLBI NIH HHS N01 HC095164NHLBI NIH HHS N01 HC095165NHLBI NIH HHS N01 HC095166NHLBI NIH HHS N01 HC095167NHLBI NIH HHS N01 HC095168NHLBI NIH HHS N01 HC095169NHLBI NIH HHS R01 HL077612NIA NIH HHS R01 AG077518NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P42 ES033719NIEHS NIH HHS R01 ES028758NIEHS NIH HHS T32 ES007322
6 · The paper itself

Abstract

backgroundExposure to metals has been associated with cardiovascular disease (CVD) end points and mortality, yet prospective evidence is limited beyond arsenic, cadmium, and lead. In this study, we assessed the prospective association of urinary metals with incident CVD and all-cause mortality in a racially diverse population of US adults from MESA (the Multi-Ethnic Study of Atherosclerosis).

methodsWe included 6599 participants (mean [SD] age, 62.1 [10.2] years; 53% female) with urinary metals available at baseline (2000 to 2001) and followed through December 2019. We used Cox proportional hazards models to estimate the adjusted hazard ratio and 95% CI of CVD and all-cause mortality by baseline urinary levels of cadmium, tungsten, and uranium (nonessential metals), and cobalt, copper, and zinc (essential metals). The joint association of the 6 metals as a mixture and the corresponding 10-year survival probability was calculated using Cox Elastic-Net.

resultsDuring follow-up, 1162 participants developed CVD, and 1844 participants died. In models adjusted by behavioral and clinical indicators, the hazard ratios (95% CI) for incident CVD and all-cause mortality comparing the highest with the lowest quartile were, respectively: 1.25 (1.03, 1.53) and 1.68 (1.43, 1.96) for cadmium; 1.20 (1.01, 1.42) and 1.16 (1.01, 1.33) for tungsten; 1.32 (1.08, 1.62) and 1.32 (1.12, 1.56) for uranium; 1.24 (1.03, 1.48) and 1.37 (1.19, 1.58) for cobalt; 1.42 (1.18, 1.70) and 1.50 (1.29, 1.74) for copper; and 1.21 (1.01, 1.45) and 1.38 (1.20, 1.59) for zinc. A positive linear dose-response was identified for cadmium and copper with both end points. The adjusted hazard ratios (95% CI) for an interquartile range (IQR) increase in the mixture of these 6 urinary metals and the corresponding 10-year survival probability difference (95% CI) were 1.29 (1.11, 1.56) and -1.1% (-2.0, -0.05) for incident CVD and 1.66 (1.47, 1.91) and -2.0% (-2.6, -1.5) for all-cause mortality.

conclusionsThis epidemiological study in US adults indicates that urinary metal levels are associated with increased CVD risk and mortality. These findings can inform the development of novel preventive strategies to improve cardiovascular health.

Indexed as

AtherosclerosisCardiovascular DiseasesMetalsAgedAged, 80 and overCadmiumCobaltCopperEthnicityFemaleHumansIncidenceMaleMiddle AgedProspective StudiesRisk FactorsCadmiumCobaltCopperMetalsTungstenUraniumZinccadmiumcardiovascular diseasecoronary diseasemetalsmortalityurine metals biomarkers

Identifiers

PMID39087344
PMCPMC11371385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.